Abiopharma

🔍 Costa Michael Lourenco (Executive)

Company: Sabra Health Care REIT, Inc. (SBRA)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Acquired 4,158 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 469,879.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: H | nature_of_ownership: By Reporting Person's IRA | shares_owned_after: 784.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: H | nature_of_ownership: By Reporting Person's Spouse's IRA | shares_owned_after: 207.00

Footnotes:

• F1: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
• F2: Includes 286,773 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.
• REMARKS: Exhibit List: Exhibit 24 - Power of Attorney